President Biden announced his intent to nominate Monica Bertagnolli to the post of NIH director.
If you saw Monica Bertagnolli dash around at the Orlando convention center at the annual meeting of the American Association for Cancer Research earlier this week, you would not have guessed that these may be her final days in the NCI director’s job.
Cancer death rates will need to drop faster—by an average of 2.7% per year versus the current rate of 2.3% per year—to achieve the Cancer Moonshot goal of a 50% reduction by 2047.
President Joe Biden is requesting a $920 million increase to the NIH budget in fiscal year 2024, a 1.93% boost. Of that amount, $503 million, or nearly 55%, is slated for NCI, keeping funding for the majority of other NIH institutes and centers at FY23 levels.
President Joe Biden mentioned cancer 13 times in his impassioned State of the Union address and placed cancer research at the top of his Unity Agenda—an indication that his administration would continue to prioritize funding for cancer research in fiscal year 2024.
The American Cancer Society has formed two roundtables—focused on breast and cervical malignancies—to eliminate disparities and improve policies and care systems.
The White House and the American Cancer Society will convene leaders in academic oncology and across public and private arenas to address challenges in breast and cervical cancers on Oct. 24 in Washington, D.C.
When you are making a point that the country that put humans on the moon also has the capacity to cure cancers, venue and timing matter. On Sept. 12, President Joe Biden chose John F. Kennedy Presidential Library and Museum—and the 60th anniversary of Kennedy’s 1962 moonshot speech—to announce his plan’s latest iteration.
President Joe Biden has announced his intent to appoint Monica Bertagnolli as the 16th director of the National Cancer Institute—and the first woman and first chair of a clinical trials cooperative group to be named to the role.
Monica Bertagnolli, first woman and first clinical trials group chair to direct the National Cancer Institute
Monica M. Bertagnolli, a professor of surgery at Harvard Medical School, stands poised to become the first woman and the first chair of a clinical trials cooperative group to be named director of the National Cancer Institute.